Meridian Bioscience/ US5895841014 /
| 2023-01-30 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 33.98USD | - | 112,605 Turnover: 3.83 mill. |
-Bid Size: - | -Ask Size: - | 1.5 bill.USD | - | 35.02 |
Assets
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 27.6100 | 27.4920 | 30.4500 | 30.5100 | 29.9950 | ||||||
| Intangible Assets | 7.8130 | 5.9310 | 29.8550 | 26.7040 | 23.1130 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 64.1810 | 60.4290 | 125.0320 | 115.9020 | 112.3240 | ||||||
| Inventories | 35.4950 | 35.8170 | 45.0570 | 41.4930 | 41.9930 | ||||||
| Accounts Receivable | 23.2320 | 26.2540 | 27.1020 | 29.1060 | 32.3360 | ||||||
| Cash and Cash Equivalents | 43.0470 | 49.9730 | 47.2260 | 57.0720 | 59.7630 | ||||||
| Current Assets | 112.7480 | 122.8530 | 126.7910 | 133.8750 | 139.0530 | ||||||
| Total Assets | 176.9290 | 183.2820 | 251.8230 | 249.7770 | 251.3770 | ||||||
Liabilities
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.9660 | 6.6460 | 7.6270 | 7.7190 | 6.2600 | ||||||
| Long-term debt | 0.0000 | 0.0000 | 54.6100 | 50.1470 | 44.9300 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | - | - | 2.8000 | 4.5000 | 3.8000 | ||||||
| Liabilities | 15.9000 | 17.4090 | 85.3510 | 80.1920 | 75.9590 | ||||||
| Share Capital | - | - | - | - | - | ||||||
| Total Equity | 161.0290 | 165.8730 | 166.4720 | 169.5850 | 175.4180 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 176.9290 | 183.2820 | 251.8230 | 249.7770 | 251.3770 | ||||||
Income Statement
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 188.8320 | 194.8300 | 196.0820 | 200.7710 | 213.5710 | ||||||
| Depreciation (total) | 5.5620 | 5.2180 | 6.6270 | 8.1180 | 7.9240 | ||||||
| Operating Result | 52.3920 | 56.0600 | 51.3780 | 37.3820 | 31.5840 | ||||||
| Interest Income | .0250 | .0230 | -.8300 | -1.4710 | -1.1020 | ||||||
| Income Before Taxes | 52.1080 | 55.0630 | 50.6440 | 36.4290 | 30.3800 | ||||||
| Income Taxes | 17.3650 | 19.5230 | 18.4150 | 14.8720 | 6.5310 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 34.7430 | 35.5400 | 32.2290 | 21.5570 | 23.8490 | ||||||
Per Share
Cash Flow
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 38.2620 | 42.8090 | 37.2230 | 41.3550 | 34.7830 | ||||||
| Cash Flow from Investing Activities | -7.0020 | -3.6260 | -66.6950 | -4.4670 | -4.2010 | ||||||
| Cash Flow from Financing | -31.7530 | -30.7430 | 27.2050 | -27.7130 | -27.5930 | ||||||
| Decrease / Increase in Cash | -1.2350 | 6.9260 | -2.7470 | 9.8460 | 2.6910 | ||||||
| Employees | - | 580 | 650 | 420 | 400 | ||||||
